日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway.

一项多方面的发现策略,通过 Wnt 非经典途径,鉴定出与 hDKK1 的富含半胱氨酸的结构域 1 结合的功能性抗体,用于癌症免疫治疗

Wang Linya, Peterson Sean M, Yang Marisa, Lujan Hernandez Ana G, Yuan Tom Z, Han Zhen, Prabhu Vishwas, Chan Kara Y, Hu Cameron F, Villalta Mouna, Htoy Tammy, VanDyke Paul, Holliday Carson, Franco Hector, Wadhwa Hansika, Giang Hoa, Stafford Ryan, Axelrod Fumiko, Sato Aaron

Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism.

优化胰高血糖素样肽-1受体拮抗剂抗体治疗高胰岛素血症

Peterson Sean M, Juliana Christine A, Hu Cameron F, Chai Jinghua, Holliday Carson, Chan Kara Y, Lujan Hernandez Ana G, Challocombe Zoe, Wang Linya, Han Zhen, Haas Nikhil, Stafford Ryan, Axelrod Fumiko, Yuan Tom Z, De León Diva D, Sato Aaron K